By Josh L Davis – IFL Science.
A team of researchers from the Ramazzini Institute claim that the sweetener sucralose, which is used in the popular brand Splenda, is linked to an increase in incidence of leukaemia.
Unfortunately, despite being reported in a few different publications, there is little evidence to back this claim up. In fact, the institute that apparently produced the results seemingly have a history of claiming to have evidence that other sweeteners such as aspartame also cause cancer, but refusing to divulge the data when requested by the European Food Safety Authority (EFSA). The new study, published in the Journal of Occupational and Environmental Health, claims that their “findings do not support previous data that sucralose is biologically inert,” and instead that they “found a significant dose-related increased incidence of males bearing malignant tumors, and a significant dose-related increased incidence of [leukemia]in males.” They fail to mention in their conclusions that they only found “significant” increases in leukemia for those male mice given doses of sucralose at 2,000 parts per million (ppm) and 16,000 ppm, but not at an intermediate 8,000 ppm. Not only that, but female mice that were fed no sweetener as a control had almost the same rate of leukaemia as the males being fed sucralose at 16,000 ppm. Cherry-picking, indeed… read the full story. [hr]